Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Pulse Biosciences, Inc (PLSE) had Weighted-Average Shares Outstanding (Diluted) of 58.40M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-53.59M |
|
-- |
|
-- |
|
$56.26M |
|
$-56.26M |
|
$2.67M |
|
$-53.59M |
|
$-53.59M |
|
$-53.59M |
|
$-53.59M |
|
$-53.59M |
|
$-53.59M |
|
$-56.26M |
|
$-55.08M |
|
58.40M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.40M |
$-0.92 |
|
$-0.92 |
|
| Balance Sheet Financials | |
$119.45M |
|
$1.16M |
|
$13.01M |
|
$132.46M |
|
$10.05M |
|
-- |
|
$7.54M |
|
$17.60M |
|
$114.86M |
|
$110.85M |
|
$114.86M |
|
65.93M |
|
| Cash Flow Statement Financials | |
$-36.34M |
|
$-0.12M |
|
$110.14M |
|
$44.37M |
|
$118.04M |
|
$73.67M |
|
$13.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.65% |
|
-48.34% |
|
-40.45% |
|
-46.65% |
|
$1.74 |
|
$-0.62 |
|
$-0.62 |
|